Effect Of Common COVID-19 Antibiotic Found Similar To That O
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The findings of a new study from UC San Francisco suggests that among non-hospitalized patients the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19. Despite widespread prescription of the antibiotic for the disease, it might increase the chance of hospitalization.

Azithromycin, a broad-spectrum antibiotic, is widely prescribed as a treatment for COVID-19 in the United States and the rest of the world. "The hypothesis is that it has anti-inflammatory properties that may help prevent progression if treated early in the disease," said the researcher.

The study included 263 participants who all tested positive for SARS-CoV-2 within seven days before entering the study. None were hospitalized at the time of enrollment. In a random selection process, 171 participants received a single, 1.2-gram oral dose of azithromycin and 92 received an identical placebo.

On day 14 of the study, 50 per cent of the participants remained symptom-free in both groups. By day 21, five of the participants who received azithromycin had been hospitalized with severe symptoms of COVID-19 and none of the placebo group had been hospitalized. The researchers concluded that treatment with a single dose of azithromycin compared to placebo did not result in a greater likelihood of being symptom-free.

Source:
https://jamanetwork.com/journals/jama/fullarticle/2782166?resultClick=1
Dr. T●●●●z H●●●●●●i and 3 others like this7 shares
Like
Comment
Share